++

The pseudomonads are a heterogeneous group of gram-negative bacteria that have in common an inability to ferment lactose. Formerly classified in the genus Pseudomonas, the members of this group are now assigned to three medically important genera—Pseudomonas, Burkholderia, and Stenotrophomonas—whose biologic behaviors encompass both similarities and marked differences and whose genetic repertoires differ in many respects. The pathogenicity of most pseudomonads is based on opportunism; the exceptions are the organisms that cause melioidosis (B. pseudomallei) and glanders (B. mallei), which can be considered primary pathogens.

++

P. aeruginosa, the major pathogen of the group, is a significant cause of infections in hospitalized patients and in patients with cystic fibrosis (CF; Chap. 259). Cytotoxic chemotherapy, mechanical ventilation, and broad-spectrum antibiotic therapy probably paved the way for increasing numbers of patients colonized and infected by this organism. Since the implementation of these advances in medical therapy, most conditions predisposing to P. aeruginosa infections have involved host compromise and/or broad-spectrum antibiotic use. The other members of the genus PseudomonasP. putida, P. fluorescens, and P. stutzeri—infect humans infrequently.

++

The genus Burkholderia comprises >40 species, of which B. cepacia is most frequently encountered in Western countries. Like P. aeruginosa, B. cepacia is both a nosocomial pathogen and a cause of infection in CF. The other medically important members of this genus are B. pseudomallei and B. mallei, which, as stated above, cause melioidosis and glanders, respectively.

++

The genus Stenotrophomonas contains one species of medical significance, S. maltophilia (previously classified in the genera Pseudomonas and Xanthomonas). This organism is strictly an opportunist that “overgrows” in the setting of potent broad-spectrum antibiotic use.

++

Epidemiology

++

P. aeruginosa is found in most moist environments. Soil, plants, vegetables, tap water, and countertops can all be reservoirs for this microbe, as it has simple nutritional needs. Given the ubiquity of P. aeruginosa, contact with the organism obviously is not sufficient for colonization or infection. Clinical and experimental observations suggest that P. aeruginosa infection often occurs concomitantly with host defense compromise, mucosal trauma, physiologic derangement, and antibiotic-mediated suppression of normal flora. Thus, it comes as no surprise that the majority of P. aeruginosa infections occur in intensive care units (ICUs), where these factors frequently converge. It is believed that the organism is initially acquired from environmental sources, but patient-to-patient spread also occurs in clinics and families.

++

Burn patients once appeared to be unusually susceptible to P. aeruginosa. For example, in 1959–1963, Pseudomonas burn-wound sepsis was the principal cause of death in 60% of burned patients dying at the U.S. Army Institute of Surgical Research. For reasons that are unclear, P. aeruginosa infection in burns is no longer the major problem that it was during the 1950s and 1960s. Similarly, in the 1960s, P. aeruginosa appeared as a common pathogen in patients receiving cytotoxic ...

Want access to your institution's subscription?

Sign in to your MyAccess Account while you are actively authenticated on this website via your institution (you will be able to tell by looking in the top right corner of any page – if you see your institution’s name, you are authenticated). You will then be able to access your institute’s content/subscription for 90 days from any location, after which you must repeat this process for continued access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess account, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessMedicine Full Site: One-Year Subscription

Connect to the full suite of AccessMedicine content and resources including more than 250 examination and procedural videos, patient safety modules, an extensive drug database, Q&A, Case Files, and more.

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessMedicine

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.